227 related articles for article (PubMed ID: 27382961)
1. Overexpression of SORCIN is a Prognostic Biomarker for Multidrug-Resistant Pediatric Acute Lymphoblastic Leukemia and Correlates with Upregulated MDR1/P-gp.
Dabaghi M; Rahgozar S; Moshtaghian J; Moafi A; Abedi M; Pourabutaleb E
Genet Test Mol Biomarkers; 2016 Sep; 20(9):516-21. PubMed ID: 27382961
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of sorcin is associated with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein.
Yamagishi N; Nakao R; Kondo R; Nishitsuji M; Saito Y; Kuga T; Hatayama T; Nakayama Y
Biochem Biophys Res Commun; 2014 Jun; 448(4):430-6. PubMed ID: 24796664
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous detection of MDR1 and WT1 gene expression to predict the prognosis of adult acute lymphoblastic leukemia.
Xu B; Song X; Yip NC; Xiao P; Zhang Y; Wang W; Zhou S
Hematology; 2010 Apr; 15(2):74-80. PubMed ID: 20423567
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
5. [Multidrug resistant gene MDR1 contributes to development of imatinib-resistance in Ph (+) acute lymphoblastic leukemia cell line SUP-BS15RI].
Lin J; Xing HY; Gong YP; Yang X; Guo Y; Shan QQ; Zhou RQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):657-60, 665. PubMed ID: 23230732
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of sorcin results in multidrug resistance in gastric cancer cells with up-regulation of P-gp.
He Q; Zhang G; Hou D; Leng A; Xu M; Peng J; Liu T
Oncol Rep; 2011 Jan; 25(1):237-43. PubMed ID: 21109982
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical implication of soluble resistance-associated calcium-binding protein gene and multi-drug resistance gene in leukemia.
Li G; Tan Y; Yang C; Zhao C; Zhao H; Wang J; Xue Y; Han M; Qian L; Zhao C
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):370-4. PubMed ID: 12408767
[TBL] [Abstract][Full Text] [Related]
8. Expression and clinical implications of the soluble drug resistance-related calcium-binding protein (sorcin) gene in leukemia patients.
Li G; Tan Y; Yang C; Zhao C; Zhao H; Wang J; Xue Y; Han M; Qian L; Zhao C
Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):293-6. PubMed ID: 12411058
[TBL] [Abstract][Full Text] [Related]
9. Changes in the MDR1 gene expression after short-term ex vivo therapy with prednisolone have prognostic impact in childhood acute lymphoblastic leukemia.
Janiszewska H; Styczynski J; Kolodziej B; Wysocki M; Haus O
Ann Hematol; 2009 Dec; 88(12):1193-8. PubMed ID: 19352661
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia.
Styczynski J; Wysocki M; Debski R; Czyzewski K; Kolodziej B; Rafinska B; Kubicka M; Koltan S; Koltan A; Pogorzala M; Kurylak A; Olszewska-Slonina D; Balwierz W; Juraszewska E; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M; Kowalczyk J; Stefaniak J; Badowska W; Sonta-Jakimczyk D; Szczepanski T; Matysiak M; Malinowska I; Stanczak E; Wachowiak J; Konatkowska B; Gil L; Balcerska A; Maciejka-Kapuscinska L
J Cancer Res Clin Oncol; 2007 Nov; 133(11):875-93. PubMed ID: 17671794
[TBL] [Abstract][Full Text] [Related]
11. Multi-drug resistance (MDR1) gene expression in de novo acute leukemia cells: correlations with CD surface markers and treatment outcome.
Jiang EZ; Chang YJ; Lee JW; Lee WK; Kim JS; Sohn SK; Lee KB; Suh JS
J Korean Med Sci; 1998 Dec; 13(6):617-22. PubMed ID: 9886170
[TBL] [Abstract][Full Text] [Related]
12. Influence of IGF-I and cell density on MDR1 expression in the T-lymphoblastoid cell line CCRF-CEM.
Schwarze CP; Neu S; Beck J; Mavridou K; Ranke MB; Binder G
Horm Res; 1999; 52(4):192-9. PubMed ID: 10725785
[TBL] [Abstract][Full Text] [Related]
13. Expression of sorcin predicts poor outcome in acute myeloid leukemia.
Tan Y; Li G; Zhao C; Wang J; Zhao H; Xue Y; Han M; Yang C
Leuk Res; 2003 Feb; 27(2):125-31. PubMed ID: 12526918
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
[TBL] [Abstract][Full Text] [Related]
15. shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.
Xu P; Jiang YF; Wang JH
Int J Clin Exp Pathol; 2015; 8(3):2300-10. PubMed ID: 26045737
[TBL] [Abstract][Full Text] [Related]
16. Profiling gene mutations, translocations, and multidrug resistance in pediatric acute lymphoblastic leukemia: a step forward to personalizing medicine.
Rose-James A; Shiji R; Kusumakumary P; Nair M; George SK; Sreelekha TT
Med Oncol; 2016 Sep; 33(9):98. PubMed ID: 27449773
[TBL] [Abstract][Full Text] [Related]
17. [A clinical study on multidrug resistance gene (MDR1) expression in acute leukemia].
Pu J; Liu H; Lou F
Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):655-8. PubMed ID: 8731823
[TBL] [Abstract][Full Text] [Related]
18. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
19. Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.
Efferth T; Sauerbrey A; Steinbach D; Gebhart E; Drexler HG; Miyachi H; Chitambar CR; Becker CM; Zintl F; Humeny A
Int J Oncol; 2003 Aug; 23(2):509-17. PubMed ID: 12851703
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of multidrug resistance gene (MDR1) at relapse in a child with acute lymphoblastic leukemia.
Kourti M; Vavatsi N; Gombakis N; Tzimagiorgis G; Sidi V; Koliouskas D; Athanassiadou F
Pediatr Hematol Oncol; 2006 Sep; 23(6):489-94. PubMed ID: 16849280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]